MOGGI PIGNONE, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.834
EU - Europa 9.140
AS - Asia 7.134
SA - Sud America 885
AF - Africa 247
Continente sconosciuto - Info sul continente non disponibili 218
OC - Oceania 126
Totale 33.584
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 15.516
RU - Federazione Russa 3.264
IT - Italia 2.172
SG - Singapore 2.115
CN - Cina 1.685
HK - Hong Kong 1.035
PL - Polonia 827
VN - Vietnam 776
IE - Irlanda 731
BR - Brasile 687
KR - Corea 596
SE - Svezia 592
DE - Germania 354
FR - Francia 320
FI - Finlandia 295
IN - India 202
GB - Regno Unito 199
CA - Canada 196
UA - Ucraina 171
BD - Bangladesh 160
AU - Australia 121
TR - Turchia 104
JO - Giordania 92
JP - Giappone 92
AR - Argentina 70
ID - Indonesia 69
CI - Costa d'Avorio 44
IQ - Iraq 42
MX - Messico 40
NL - Olanda 38
ES - Italia 35
ZA - Sudafrica 33
EC - Ecuador 32
CO - Colombia 29
MA - Marocco 27
CH - Svizzera 25
NG - Nigeria 23
EG - Egitto 22
VE - Venezuela 22
PH - Filippine 20
BJ - Benin 19
PK - Pakistan 19
TN - Tunisia 18
JM - Giamaica 17
PY - Paraguay 17
AT - Austria 16
BE - Belgio 16
KE - Kenya 16
TH - Thailandia 15
UZ - Uzbekistan 14
CR - Costa Rica 13
SA - Arabia Saudita 13
MY - Malesia 12
TT - Trinidad e Tobago 11
CL - Cile 10
PE - Perù 10
LT - Lituania 9
NP - Nepal 9
CZ - Repubblica Ceca 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
DZ - Algeria 7
EE - Estonia 7
HN - Honduras 7
KZ - Kazakistan 7
PT - Portogallo 7
HU - Ungheria 6
IL - Israele 6
NI - Nicaragua 6
SC - Seychelles 6
SD - Sudan 6
CM - Camerun 5
LB - Libano 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
RO - Romania 5
TW - Taiwan 5
UY - Uruguay 5
AZ - Azerbaigian 4
ET - Etiopia 4
GT - Guatemala 4
KG - Kirghizistan 4
NO - Norvegia 4
PA - Panama 4
SV - El Salvador 4
BG - Bulgaria 3
BO - Bolivia 3
BS - Bahamas 3
BW - Botswana 3
BY - Bielorussia 3
GE - Georgia 3
HR - Croazia 3
KH - Cambogia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
LY - Libia 3
MD - Moldavia 3
OM - Oman 3
PR - Porto Rico 3
PS - Palestinian Territory 3
Totale 33.322
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.733
Ashburn 1.930
Singapore 1.507
Fairfield 1.112
Hong Kong 848
Warsaw 822
Chandler 798
Dublin 723
San Jose 716
Seoul 589
Woodbridge 491
Seattle 447
Cambridge 439
Milan 421
Beijing 386
Wilmington 370
Houston 369
Hefei 306
Jacksonville 274
Florence 272
Ho Chi Minh City 272
Council Bluffs 252
Buffalo 230
Los Angeles 229
Rome 201
Princeton 195
Lauterbourg 191
The Dalles 182
Ann Arbor 181
Hanoi 166
Altamura 165
Lawrence 165
Moscow 147
Dallas 146
Boston 138
Boardman 131
Munich 129
New York 117
Melbourne 116
Medford 112
Mumbai 95
Phoenix 93
Helsinki 89
São Paulo 89
Tokyo 87
Chicago 81
Paris 79
San Diego 77
Izmir 67
Naples 67
Shanghai 67
Kent 59
Turin 55
Toronto 47
Abidjan 44
Turku 44
Falls Church 40
Bologna 39
Jakarta 39
Frankfurt am Main 38
Dong Ket 37
Da Nang 36
Montreal 36
Palermo 36
Orem 35
Redondo Beach 35
Norwalk 34
Atlanta 33
Yubileyny 33
London 30
Brooklyn 29
Guangzhou 28
Figino 27
Pune 26
Denver 25
Philadelphia 23
Bari 22
San Francisco 22
Abuja 21
Columbus 21
Washington 21
Andover 20
Genoa 20
Catania 19
Chennai 19
Clifton 19
Cotonou 19
Hillsboro 19
Johannesburg 19
Baghdad 18
Haiphong 18
Belo Horizonte 17
Poplar 17
Biên Hòa 16
Shenzhen 16
Verona 16
Brasília 15
Cagliari 15
Mexico City 15
Miano 15
Totale 21.256
Salva come PNG Salva come JPEG
Nome #
Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis 353
[Peripheral nervous system in limited systemic sclerosis]. 340
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). 337
Doppler ultrasound unveils splanchnic arteries ischemia allowing early successful revascularization in symptomatic systemic sclerosis patients 304
Assessment, definition, and classification of lower limb ulcers in systemic sclerosis: A challenge for the rheumatologist 256
Left atrial dysfunction detected by speckle tracking in patients with systemic sclerosis. 255
Lack of activation of renal functional reserve predicts the risk of significant renal involvement in systemic sclerosis. 248
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction 248
Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit 246
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 245
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 245
Biohumoral markers as predictor of right ventricular dysfunction in AL Amyloidosis. 243
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 231
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline 230
A rare case of Candida glabrata spondylodiscitis: case report and literature review 220
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 216
Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study. 216
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 212
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis. 212
Acute heart failure in the elderly: setting related differences in clinical features and management 211
Prophylactic activity of increasing doses of intravenous histamine in refractory migraine: Retrospective observations of a series of patients with migraine without aura 210
Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers 210
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 205
Liver dysfunction as predictor of prognosis in patients with amyloidosis: utility of the Model for End-stage Liver disease (MELD) scoring system 205
The platypnea-orthodeoxia syndrome: an unusual case of dyspnea 203
Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis 200
Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis 199
Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy 199
Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis. 198
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 197
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis 195
Accuracy of lung ultrasound performed with handheld ultrasound device in internal medicine: an observational study 192
Letter to Habets JGV et al. on “A rare case of Candida glabrata spondylodiscitis: case report and literature review” 192
Therapeutic challenges for systemic sclerosis: facts and future targets. 191
A case of persistent hiccup after laparoscopic cholecystectomy. 191
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 191
Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation 190
Dimensions of psychological dysfunction in patients with fibromyalgia: development of an Italian questionnaire. 190
HFmrEF in elderly patients hospitalised for acute heart failure: data from the ATHENA registry 190
Oxidative stress in Systemic Sclerosis. 189
Systemic amyloidosis: a challenge for the rheumatologist. 187
Incidence and characteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting 187
Amyloidoses 184
Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype 184
Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. 183
Therapeutic challenges for systemic sclerosis: facts and future targets. 182
The safety of iloprost in systemic sclerosis in a real-life experience 182
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis 182
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database 180
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES 179
Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement. 179
Dural metastasis without subdural hematoma or subdural fluid collection in a patient with signet ring cell gastric adenocarcinoma 178
Acute heart failure in the elderly: real world evidence from the ATHENA registry 177
Bcl-2, p53 and c-myc expression in juvenile dermatomyositis. 176
Are disease-related pulmonary perfusion abnormalities detectable in COVID-19 patients? Suspicious findings in a lung perfusion SPECT performed for ruling out classical pulmonary embolism 176
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. 176
EULAR EVIDENCE BASED RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGMENT OF GOUT 173
The classification of hospitalized patients with hyperglycemia and its implication on outcome: results from a prospective observational study in Internal Medicine 173
The doctor who stared at schistocytes: an intriguing case of suspected thrombotic microangiopathic anemia 173
Effect of melatonin on normal and sclerodermic skin fibroblast proliferation. 172
HFrEF, HFmrEF and HFpEF: which is the treatment of choice at discharge? Real world data from the ATHENA registry 171
Angiotensin converting enzyme a new tool for the follow-up of endothelial injury in paediatric vasculitides. 170
Valutazione circadiana dell’ attività fibrinolitica circolante nella Sclerosi Sistemica. 170
Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes. 169
Current Treatment Options in Raynaud's Phenomenon. 169
Acute heart failure in the real world: are elderly patients managed in accordance to current guidelines? Data from the ATHENA registry 169
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes. 169
Discrepant expression of neprilysin on fibroblasts in diffuse systemic sclerosis. 168
Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarciodosis 168
A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis   167
ULTRASOUND (US) EVALUATION OF BOWEL VASCULOPATHY IN SYSTEMIC SCLEROSIS (SSC) 166
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. 166
ANGIOTENSIN CONVERTING ENZYME A NEW TOOL FOR THE FOLLOW-UPOF ENDOTHELIAL INJURY IN PEDIATRIC VASCULITIDES 166
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) 166
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening 166
[Patterns of ventricular late potentials in systemic sclerosis: a noninvasive method in the study of cardiac involvement]. 165
The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review 164
HFmrEF in elderly patients: the pathogenetic role of ischemia. Real world data from the ATHENA registry 164
Acute heart failure in the elderly: which are the main precipitating causes of heart failure? Real world evidence from the ATHENA registry 164
Oral lactobacillus species in systemic sclerosis 164
Pulmonary Circulation on the Crossroads Between the Left and Right Heart in Systemic Sclerosis: A Clinical Challenge for Cardiologists and Rheumatologists 163
Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression 162
Pulmonary arterial hypertension and rheumatic diseases--from diagnosis to treatment. 160
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis 160
The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases 159
Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment. 159
Central nervous system hemangiopericytoma with bone and lung metastases: a case report. 159
The renal resistive index: A new biomarker for the follow-up of vascular modifications in systemic sclerosis 159
Patients' unmet needs and treatment preferences concerning digital ulcers in systemic sclerosis 158
High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. 157
Urokinase-type plasminogen activator is the main plasminogen activator produced by synoviocytes of osteoarthritis and rheumatoid arthitis 156
Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement 156
Diene-conjugates and antibodies against oxidized low-density lipoproteins in systemic sclerosis. 156
Pulmonary arterial hypertension in systemic sclerosis: diagnostic pathway and therapeutic approach. 155
POS1593-HPR GASTROINTESTINAL INVOLVEMENT IS ALREADY REPORTED IN AN ITALIAN VEDOSS COHORT: RESULTS FROM A RHEUMATOLOGICAL NURSE ASSESSMENT 155
Hemorheologic profile in systemic sclerosis: role of NOS3 -786T > C and 894G >T polymorphisms in modulating both the hemorheologic parameters and the susceptibility to the disease. 154
Tako-Tsubo like syndrome in systemic sclerosis: a sign of myocardial Raynaud Phenomenon? 153
Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease? 153
Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis 152
"Autoimmunity part D; Autoimmune disease, annus mirabilis" - Chapter: Flow-mediated vasodilation and carotid intima-media thickness in sistemi sclerosis 152
Totale 19.067
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.645
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.645
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.055 0 0 0 68 66 116 46 69 62 64 192 372
2022/20233.088 337 542 117 266 244 576 393 157 292 24 88 52
2023/20241.333 67 137 203 59 87 207 70 242 25 90 94 52
2024/20258.702 298 872 554 1.446 2.424 995 261 422 480 262 339 349
2025/202611.032 1.207 1.415 900 725 1.221 433 1.412 540 713 649 453 1.364
2026/20272.343 403 535 1.084 321 0 0 0 0 0 0 0 0
Totale 33.584